AZN logo

AstraZeneca (AZN) Total liabilities

annual total liabilities:

$63.16B+$1.21B(+1.95%)
December 31, 2024

Summary

  • As of today (April 13, 2025), AZN annual total liabilities is $63.16 billion, with the most recent change of +$1.21 billion (+1.95%) on December 31, 2024.
  • During the last 3 years, AZN annual total liabilities has fallen by -$2.91 billion (-4.41%).
  • AZN annual total liabilities is now -4.41% below its all-time high of $66.08 billion, reached on December 31, 2021.

Performance

1-year change

+1.95%

3-year change

-4.41%

5-year change

+35.02%

15-year change

+35.22%

AZN Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.87%
AZN annual total liabilities is higher than 98.87% of companies in Healthcare sector

Range

All-time high

$66.08B
AZN annual total liabilities is currently -4.41% below its historical high of $66.08 billion

3-year low

$59.42B
AZN annual total liabilities is currently +6.29% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
AZN previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
AZN next annual earnings announcement has not yet been scheduled

OtherAZNbalance sheet metrics

quarterly current liabilities

-
AZN quarterly total current liabilities value is unknown

quarterly long term liabilities

-
AZN quarterly total long term liabilities value is unknown

quarterly total assets

-
AZN quarterly total assets value is unknown

quarterly current assets

-
AZN quarterly total current assets value is unknown

quarterly total liabilities:

N/A
December 31, 2024

Summary

  • AZN quarterly total liabilities is not available.

Performance

3-month change

-

1-year change

-

3-year change

-

5-year change

-

AZN quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

$67.31B
AZN quarterly total liabilities is currently at an all-time high

3-year low

$58.87B
AZN quarterly total liabilities is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Dec 31, 2024
AZN previous earnings announcement was published on Dec 31, 2024

Next quarterly earnings report date

Apr 29, 2025
AZN next earnings announcement is scheduled for Apr 29, 2025

OtherAZNbalance sheet metrics

quarterly current liabilities

-
AZN quarterly total current liabilities value is unknown

quarterly long term liabilities

-
AZN quarterly total long term liabilities value is unknown

quarterly total assets

-
AZN quarterly total assets value is unknown

quarterly current assets

-
AZN quarterly total current assets value is unknown

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

annual total liabilities

$63.16B
AZN annual total liabilities is $63.16 billion

annual current liabilities

$27.87B
AZN annual total current liabilities is $27.87 billion

Annual Total long term liabilities

$35.30B
AZN annual total long term liabilities is $35.30 billion

AZN Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1.9%-
3 y3 years-4.4%-
5 y5 years+35.0%-

AZN Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-4.4%+6.3%
5 y5-year-4.4%+35.0%
alltimeall time-4.4%+1275.1%

AstraZeneca Total liabilities History

DateAnnualQuarterly
Dec 2024
$63.16B(+2.0%)
-
Sep 2024
-
$64.12B(-1.0%)
Jun 2024
-
$64.74B(-0.1%)
Mar 2024
-
$64.79B(+10.1%)
Dec 2023
$61.95B(+4.3%)
-
Sep 2023
-
$58.87B(-0.4%)
Jun 2023
-
$59.13B(-2.9%)
Mar 2023
-
$60.88B(+2.4%)
Dec 2022
$59.42B(-10.1%)
$59.42B(+0.7%)
Sep 2022
-
$59.03B(-2.6%)
Jun 2022
-
$60.63B(-5.1%)
Mar 2022
-
$63.91B(-3.3%)
Dec 2021
$66.08B(+29.3%)
$66.08B(-1.8%)
Sep 2021
-
$67.31B(+16.2%)
Jun 2021
-
$57.95B(+14.8%)
Mar 2021
-
$50.48B(-1.2%)
Dec 2020
$51.09B(+9.2%)
$51.09B(+1.2%)
Sep 2020
-
$50.49B(+9.1%)
Jun 2020
-
$46.27B(+2.8%)
Mar 2020
-
$44.99B(-3.8%)
Dec 2019
$46.78B(+0.4%)
$46.78B(+3.4%)
Sep 2019
-
$45.24B(-3.4%)
Jun 2019
-
$46.82B(-4.5%)
Mar 2019
-
$49.03B(+5.2%)
Dec 2018
$46.61B(-0.2%)
$46.61B(-2.7%)
Sep 2018
-
$47.91B(+1.8%)
Jun 2018
-
$47.07B(-3.4%)
Mar 2018
-
$48.71B(+4.3%)
Dec 2017
$46.71B(+1.9%)
$46.71B(-4.9%)
Sep 2017
-
$49.14B(-1.1%)
Jun 2017
-
$49.71B(+7.6%)
Mar 2017
-
$46.18B(+0.7%)
Dec 2016
$45.86B(+10.4%)
$45.86B(-5.1%)
Sep 2016
-
$48.31B(-1.5%)
Jun 2016
-
$49.03B(+2.8%)
Mar 2016
-
$47.68B(+14.8%)
Dec 2015
$41.55B(+6.7%)
$41.55B(+13.1%)
Sep 2015
-
$36.75B(-0.3%)
Jun 2015
-
$36.87B(+0.3%)
Mar 2015
-
$36.74B(-5.7%)
Dec 2014
$38.95B(+19.3%)
$38.95B(+9.1%)
Sep 2014
-
$35.70B(-2.2%)
Jun 2014
-
$36.49B(-3.8%)
Mar 2014
-
$37.91B(+16.1%)
Dec 2013
$32.65B(+10.3%)
$32.65B(+6.4%)
Sep 2013
-
$30.67B(+0.3%)
Jun 2013
-
$30.57B(+2.5%)
Mar 2013
-
$29.84B(+0.9%)
Dec 2012
$29.59B(+0.8%)
$29.59B(-2.0%)
Sep 2012
-
$30.19B(+3.6%)
Jun 2012
-
$29.15B(+0.4%)
Mar 2012
-
$29.04B(-1.1%)
Dec 2011
$29.36B(-10.2%)
$29.36B(+3.3%)
Sep 2011
-
$28.42B(-4.0%)
Jun 2011
-
$29.59B(-7.5%)
Mar 2011
-
$31.99B(-2.2%)
Dec 2010
$32.72B
$32.72B(-4.0%)
DateAnnualQuarterly
Sep 2010
-
$34.08B(+5.2%)
Jun 2010
-
$32.38B(-2.4%)
Mar 2010
-
$33.19B(-2.7%)
Dec 2009
$34.10B(+10.4%)
$34.10B(+5.4%)
Sep 2009
-
$32.35B(+0.3%)
Jun 2009
-
$32.26B(+4.1%)
Mar 2009
-
$30.99B(+0.3%)
Dec 2008
$30.89B(-6.5%)
$30.89B(-3.4%)
Sep 2008
-
$31.97B(-6.3%)
Jun 2008
-
$34.11B(+1.5%)
Mar 2008
-
$33.59B(+1.7%)
Dec 2007
$33.04B(+127.6%)
$33.04B(+5.9%)
Sep 2007
-
$31.21B(-4.4%)
Jun 2007
-
$32.63B(+110.0%)
Mar 2007
-
$15.54B(+7.1%)
Dec 2006
$14.52B(+30.2%)
$14.52B(+8.8%)
Sep 2006
-
$13.34B(-0.8%)
Jun 2006
-
$13.45B(-7.3%)
Mar 2006
-
$14.52B(+30.2%)
Dec 2005
$11.15B(-0.1%)
$11.15B(-0.1%)
Sep 2005
-
$11.16B(-1.4%)
Jun 2005
-
$11.31B(+1.5%)
Mar 2005
-
$11.15B(-0.1%)
Dec 2004
$11.15B(+8.1%)
$11.15B(+16.8%)
Sep 2004
-
$9.55B(-17.2%)
Jun 2004
-
$11.54B(+1.5%)
Mar 2004
-
$11.37B(+10.2%)
Dec 2003
$10.32B(-0.3%)
$10.32B(+8.7%)
Sep 2003
-
$9.49B(+0.8%)
Jun 2003
-
$9.42B(-9.1%)
Mar 2003
-
$10.36B(+0.1%)
Dec 2002
$10.35B(+16.7%)
$10.35B(+15.2%)
Sep 2002
-
$8.98B(-2.5%)
Jun 2002
-
$9.21B(-3.0%)
Mar 2002
-
$9.50B(+7.1%)
Dec 2001
$8.87B(-0.3%)
$8.87B(-2.7%)
Sep 2001
-
$9.11B(+2.5%)
Jun 2001
-
$8.90B(-6.8%)
Mar 2001
-
$9.54B(+7.3%)
Dec 2000
$8.90B(-6.1%)
$8.90B(-7.4%)
Sep 2000
-
$9.60B(+3.5%)
Jun 2000
-
$9.28B(+4.5%)
Mar 2000
-
$8.88B(-6.3%)
Dec 1999
$9.47B(+26.4%)
$9.47B(+9.8%)
Sep 1999
-
$8.63B(+2.3%)
Jun 1999
-
$8.43B(+12.5%)
Dec 1998
$7.50B(+60.9%)
$7.50B(+56.1%)
Jun 1998
-
$4.80B(+3.1%)
Dec 1997
$4.66B(-5.0%)
$4.66B(-5.0%)
Dec 1996
$4.90B(+1.4%)
$4.90B(+1.4%)
Dec 1995
$4.83B(+5.2%)
$4.83B(+2.4%)
Jun 1995
-
$4.72B(+2.8%)
Dec 1994
$4.59B(-9.9%)
$4.59B(-9.9%)
Dec 1993
$5.10B(-15.3%)
$5.10B
Dec 1992
$6.02B(+10.5%)
-
Dec 1991
$5.45B(+0.5%)
-
Dec 1990
$5.42B
-

FAQ

  • What is AstraZeneca annual total liabilities?
  • What is the all time high annual total liabilities for AstraZeneca?
  • What is AstraZeneca annual total liabilities year-on-year change?
  • What is the all time high quarterly total liabilities for AstraZeneca?

What is AstraZeneca annual total liabilities?

The current annual total liabilities of AZN is $63.16B

What is the all time high annual total liabilities for AstraZeneca?

AstraZeneca all-time high annual total liabilities is $66.08B

What is AstraZeneca annual total liabilities year-on-year change?

Over the past year, AZN annual total liabilities has changed by +$1.21B (+1.95%)

What is the all time high quarterly total liabilities for AstraZeneca?

AstraZeneca all-time high quarterly total liabilities is $67.31B
On this page